AVPR1B
Vasopressin V1b receptor
Also known as: AVPR3, V1bR, V1BR_HUMAN, VPR3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P47901
- Gene
- AVPR1B
- Ensembl
- ENSG00000198049
- Chromosome
- 1
- Canonical length
- 424 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene acts as receptor for arginine vasopressin. This receptor belongs to the subfamily of G-protein coupled receptors which includes AVPR1A, V2R and OXT receptors. Its activity is mediated by G proteins which stimulate a phosphatidylinositol-calcium second messenger system. The receptor is primarily located in the anterior pituitary, where it stimulates ACTH release. It is expressed at high levels in ACTH-secreting pituitary adenomas as well as in bronchial carcinoids responsible for the ectopic ACTH syndrome. A spliced antisense transcript of this gene has been reported but its function is not known. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
424 residues, UniProt reviewed canonical sequence.
>P47901|AVPR1B
1 MDSGPLWDAN PTPRGTLSAP NATTPWLGRD EELAKVEIGV LATVLVLATG GNLAVLLTLG
61 QLGRKRSRMH LFVLHLALTD LAVALFQVLP QLLWDITYRF QGPDLLCRAV KYLQVLSMFA
121 STYMLLAMTL DRYLAVCHPL RSLQQPGQST YLLIAAPWLL AAIFSLPQVF IFSLREVIQG
181 SGVLDCWADF GFPWGPRAYL TWTTLAIFVL PVTMLTACYS LICHEICKNL KVKTQAWRVG
241 GGGWRTWDRP SPSTLAATTR GLPSRVSSIN TISRAKIRTV KMTFVIVLAY IACWAPFFSV
301 QMWSVWDKNA PDEDSTNVAF TISMLLGNLN SCCNPWIYMG FNSHLLPRPL RHLACCGGPQ
361 PRMRRRLSDG SLSSRHTTLL TRSSCPATLS LSLSLTLSGR PRPEESPRDL ELADGEGTAE
421 TIIFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AVPR1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 14 nTPM
- cerebellum: 0.4 nTPM
- stomach: 0.4 nTPM
- pancreas: 0.3 nTPM
- duodenum: 0.2 nTPM
- rectum: 0.2 nTPM
Single-cell type
- corticotrophs: 57 nCPM
- endometrial glandular cells: 14 nCPM
- endometrial luminal cells: 12 nCPM
- hematopoietic stem cells: 11 nCPM
- neuroendocrine cells: 10 nCPM
- endometrial ciliated cells: 4.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 0.5 nTPM
- thalamus: 0.5 nTPM
- cerebellum: 0.4 nTPM
- hypothalamus: 0.3 nTPM
- cerebral cortex: 0.2 nTPM
- medulla oblongata: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.35
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to hormone stimulus
- G protein-coupled receptor signaling pathway
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of arachidonate secretion
- positive regulation of cytosolic calcium ion concentration
- positive regulation of inositol phosphate biosynthetic process
- positive regulation of MAPK cascade
- positive regulation of vasoconstriction
- regulation of cell population proliferation
- regulation of systemic arterial blood pressure by vasopressin
- symbiont entry into host cell
- transport across blood-brain barrier
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AVPR1B as an antibody target. Whether an autoantibody or antibody against AVPR1B could matter depends on whether native AVPR1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AVPR1B is annotated at the cell surface, where native AVPR1B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AVPR1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...